Keybank National Association Macrogenics Inc Transaction History

Keybank National Association

  • $25.6 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 30, 2019
SELL
$11.75 - $21.42 $111,495 - $203,254
-9,489 Closed
0 $0
Q3 2018

Nov 08, 2018
BUY
$19.26 - $23.46 $182,758 - $222,611
9,489 New
9,489 $203,000
Q2 2018

Aug 08, 2018
SELL
$19.78 - $24.67 $165,360 - $206,241
-8,360 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$18.89 - $32.46 $157,920 - $271,365
8,360 New
8,360 $210,000

Others Institutions Holding MGNX

# of Institutions
131
Shares Held
56M
Call Options Held
28.3K
Put Options Held
197K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $170M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email